Get started

Coronavirusstocks

Top Ways to Make Serious Money in StocksEveryone who was reading our reports yesterday was prepared for the big correction in stocks yesterday! Some of our traders made serious money off this! Recall that we mentioned that stocks were having trouble with all time highs and that it was realistic for a correction before they could make a run to solidly break all time highs. We explicitly called out the level 3357. Note that now, the Kovach indicators are solidly bullish, indicating that there was a substantial buy back at the levels we identified. Perhaps this means people are paying attention to our reports :) Stocks are likely to maintain this range as they feel out the new territory, at least for a bit before gunning for new highs. We are still bullish of stocks, though it is hard to ignore the impending bubble. Until we hit systemic defaults from great depression level unemployment, we can expect this party to continue.
FX:SPX500Long
by quantguy
WAVE.V -- Bottoming Out Undervalued Pharma/COVID-19 PlayThe most attractive part of WAVE.V is share structure: 54M total float with 41M shares held by insiders / escrowed, leaving about 13M shares free trading. The company owns a portfolio of generic oncology drugs from which it generates over $300K of quarterly revenue. $1M in cash on hand. Based on last financials, they are $83K away from generating positive cash flow and recent developments suggest they will get there sooner rather than later: -- Received grant to develop a rapid COVID-19 saliva based test in partnership with the University of Manitoba -- Received authorization from several EU countries to expand sales of their generic oncology drugs -- Expecting FDA authorization in Q4 2020 At below $10M mkt cap and in the absence of any cheap paper overhang, I feel that this is a tremendous opportunity. Compare it to something like THRM.V which is developing a similar saliva-based COVID-19 test, has next to nothing in revenues, a ton of cheap paper, 3x the float and 3x the market cap, and you realize that current valuation makes no sense. Chart suggests the stock is reversing from short term downtrend after finding bottom at .15. A doji, followed by green candle on increased volume and EMA 20 crossing above EMA 50 providing additional support at .16. Today was a pullback on lower volume that resulted in a higher low. I used it as an opportunity to pad my position. Next catalysts that could propel sp to significantly higher levels are updates on the oncology drug sales in Europe, rapid COVID-19 test development progress and FDA approval of oncology drugs for sale/marketing in the US.
WLong
by wealth_bakery
Is Netflix Flying a Bearish Flag?Investors are rotating back to “reopening” sectors like airlines, financials and energy. This runs against the dominant theme for most of the coronavirus period, which focused on stay-at-home stocks. Netflix is obviously one of the biggest examples of that “Covid trade.” Not surprisingly, it’s lagged recently as other parts of the market have taken off. The chart also has some bearish patterns. First and foremost was the large “blowoff top” on July 13. This appeared on most major technology stocks and Nasdaq constituents (except semiconductors). It also produced a bearish outside candle for the Nasdaq-100. NFLX has remained entirely below this large bearish candle for more than three weeks – a sign of resistance taking hold. Next, the streaming-video stock followed an uptrend since March that it’s now violating. Its last attempt to hold that line now look like a bearish flag that’s broken to the downside. Finally, the fundamentals aren’t so hot. NFLX obviously benefited from an initial surge of business as lockdowns spread. (Q1 subs +16mln.) But last quarter executives bluntly admitted “we expect less growth” in the future. (The main reason seems to be that many would-be signups were only shifted forward in time.) Given the macro backdrop and slowing fundamentals, it may be too early to “buy the dip” in NFLX. The next big level to watch on NFLX is the July 24 low of $467.54. Selling could increase if the stock closes under that.
NASDAQ:NFLX
by TradeStation
SONA.C -- Potential bounce opportunity from historical supportSONA shaved off close to 60% off its recent highs after news of 2 week delay for FDA approval of their COVID-19 test kits. Nothing has changed fundamentally and, if you read the NR carefully, they are lining up more customers and shipping kit prototypes under research license. NASDAQ uplisting is pending as well. The stock has landed in the historical support zone, almost exactly at EMA 50. Additional Fib support right below. This is a good speculative entry here for a bounce with multiple catalysts pending. A stop just below Fib. support may be a good idea.
CSE:SONALong
by wealth_bakery
3
[NVAX] Novavax: Preliminary studies produce promising resultsPreliminary studies on coronavirus vaccines have produced promising results. I'm still a believer in their technology. Check out my previous NVAX posts and/or the first one. They have a promising technology that could revolutionize the vaccine industry. We (humanity) are already very behind in how we produce vaccines AKA using chicken eggs. So Novavax will hopefully pave the way for vaccines going forward. Things to watch even after COVID-19: - NanoFlu™ - ResVax™ - Recombinant Nanoparticle Vaccine Technology - Matrix-M™ Adjuvant Technolog TL;DR - To the moon and (probably) back lol *Note: This is pure speculation and my own opinion* NY Times: www.nytimes.com CNBC: www.cnbc.com
NASDAQ:NVAXLong
by traderman001
2
FCC Approved Contactless Temperature Scanner - Options ActivityJune 8, 2020 Remark Holdings (MARK) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices. Remark offers products that will help in the crisis and the company owns a stake in Sharecare, the medical startup co-founded by celebrity doctor Mehmet Oz and backed by Oprah Winfrey and Sony (NYSE:SNE). Remark’s innovative products include thermal imaging and scanning solutions that are already in use in Nevada. This artificial intelligence-driven tech can “scan high traffic areas to detect individuals with higher than acceptable skin temperature,” the Wall Street Journal reports. LAS VEGAS, May 27, 2020 /PRNewswire/ -- Remark Holdings, Inc. (NASDAQ: MARK), a diversified global technology company with leading artificial intelligence ("AI") solutions and digital media properties, today announced the launch of a new website, RemarkThermal.com. "Interest in our thermal imaging and scanning solutions is robust across many industries and we believe that enthusiasm warrants a dedicated site for information about our novel solutions," stated Kai-Shing Tao, Chairman and Chief Executive Officer of Remark Holdings, Inc. "What differentiates Remark's thermal cameras are its capabilities beyond thermal temperature scanning. Our proprietary AI software enables monitoring various tasks including people counting, PPE enforcement such as mask wearing, social distancing compliance, contactless access to doors and gates, attendance management, touchless employee check in, object counts, behavior detection, intelligent surveillance and theft control." Remark's Thermal Imaging is used to scan high traffic areas to detect individuals with higher than acceptable skin temperature and track the subject for secondary screening. Each of the Thermal Imaging products is customizable and can operate as a standalone or integrated into centralized control systems, specific to the needs of the customer. Real-time video and audible alerts from individual systems can be sent to a centralized system or monitored live. Systems can be mounted on walls, tripods, or ceilings to scan wider areas. For additional information, please refer to: www.RemarkThermal.com. Options are active. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
MLong
by HotCharts
6
[INO] Technically Oversold but Coronavirus Stocks are VolatileINO's narrow, steep channel makes no sense, it'll break below channel line and correct into new downward channel likely falling along with overall market in June. Avg. cost: $7.28 Sold 20% at $11.63 (~50% profit mark), 20% at $13.30 (~100% profit mark) and 20% at $16.09 today (rough peak estimate). Will hold the remaining 40% just cuz who knows if some trial or study or funding announcement drops but I do expect it to fall back down and would love a chance to re-up here around $10. Even POC (white line) of $13 is probably still a bit overpriced. Dripping in FOMO here.
NASDAQ:INOShort
by ProfitHarvest
Received Contract for COVID-19 Screening JFK Airport - OMG!I just found this stock searching online for COVID-19 screening at JFK Airport. Today, this company received a contract for coronavirus screening in airports. Where can this stock go...? Your guess is as good as mine but for now, I think this is the only company that has a contract for screening at airports! Is the sky the limit? If the company receives more contracts for more airports, this stock could blast off! What do I have to lose? Long!
XLong
by HotCharts
[NVAX] Sliding Back to $40, Collapse if It Breaks ThroughI missed this guy when I jumped on MRNA and INO earlier this week. Just trying to pin this one down a bit, coronavirus stocks are wild and fun :). For FOMO stocks, typical support and resistance horizontal lines aren't as predictive and you should instead look to the Volume Profile. Support should be right around the POC, which is $40. It should slide down to that and hang a bit before breaking through and crashing down. May bounce back up too but seems unlikely. All indicators are lining up at the start of a downward channel and signaling a short move too. June market crash is probably gonna move this more than anything as retail tries to secure their tiny profits or stem their massive losses.
NASDAQ:NVAXShort
by ProfitHarvest
8
[MRNA] Attempting to Pin Down Hyperbolic FOMO... Gonna Tank?Nothing too serious here, just an observer on this one. One of my biggest regrets, I pumped money into INO instead of MRNA when they were both cheap when the smart play was covering the field. Noob move... alas, there's always another stock to chase. Anyway, here's a decent stock architecture for anyone playing this. Basically I'm just hoping it dips super low temporarily to $30-$40 on a market crash or something and would absolutely pick this up, otherwise it's long gone outside my playing field. Who knows, maybe it'll collapse anyway simply without enough news to keep it pumped, we'll see. Vaccine news will pump and dump these stocks for the next 18 months lol so great segment to jump into if you're swing trading. Probably not the best idea to buy now. Vaccine (and revenue!) is 12-18 months away. Hype alone won't hold these prices up.
NASDAQ:MRNAShort
by ProfitHarvest
Draft Kings BubbleIN MY OPINION The coronavirus has sparked a lot of interest in people with (extra money) stimulus checks/unemployment and (extra time) unemployed. When things go back to "normal" and people go back to their regularly scheduled days they will forget about gambling with draft kings but not all of them. I think there will be a solid price range that it will hang around... Right now the most resistance I've seen is around 18.68 and 11.43 for support. Of course price action isn't the only thing to factor in what a company is worth.. I will be looking to short this once momentum slows down.
NASDAQ:DKNGShort
by JakeBrandonCastro
8
Zoom to end their call? Prospectus...A classic head and shoulders by the almighty Zoom. It's not unlikely that their run is coming to an end, but we could see a bit of upside before we suffer downside. I would expect a bit more reactionary price action before the main crash. We have a textbook Head and Shoulders forming, with a consistent neckline in line with the hourly open. This has been a stock I've been following for a long time, and I've had the Head and Shoulders idea since the 24th April, or its second peak. It's very difficult to analyse stocks, as they tend to follow fundamnetals more - but I'm really confident on this one. It's not often that the H&S pattern fails, let alone reverses. We shall see how this plays out alongside the falling volume. Be careful with this idea, as it could reverse for a second time. Place a stop loss where you can afford to take losses - I have placed a potential point of entry on the chart, but personally I will enter here - as I can afford to do so due to my level of margin. Trade responsibly. NFA
NASDAQ:ZMShort
by lndlsnt